Alpha 2.0
Login Register
» Articles » PMID: 10491389

Regulation of P21(cip1) Expression by Growth Factors and the Extracellular Matrix Reveals a Role for Transient ERK Activity in G1 Phase

Overview
Journal J Cell Biol
Specialty Cell Biology
Date 1999 Sep 24
PMID 10491389
Citations 38
Authors
M E Bottazzi
X Zhu
R M Bohmer
R K Assoian
Affiliations
Soon will be listed here.
Abstract

We have examined the regulation of p21(cip1) by soluble mitogens and cell anchorage as well as the relationship between the expression of p21(cip1) and activation of the ERK subfamily of MAP kinases. We find that p21(cip1) expression in G1 phase can be divided into two discrete phases: an initial induction that requires growth factors and the activation of ERK, and then a subsequent decline that is enhanced by cell anchorage in an ERK-independent manner. In contrast to the induction of cyclin D1, the induction of p21(cip1) is mediated by transient ERK activity. Comparative studies with wild-type and p21(cip1)-null fibroblasts indicate that adhesion-dependent regulation of p21(cip1) is important for proper control of cyclin E-cdk2 activity. These data lead to a model in which mitogens and anchorage act in a parallel fashion to regulate G1 phase expression of p21(cip1). They also show that (a) growth factors and growth factor/extracellular matrix cooperation can have different roles in regulating G1 phase ERK activity and (b) both transient and sustained ERK signals have functionally significant roles in controlling cell cycle progression through G1 phase.

Citing Articles

Integrative modeling uncovers p21-driven drug resistance and prioritizes therapies for PIK3CA-mutant breast cancer.

Yip H, Shin S, Chee A, Ang C, Rossello F, Wong L NPJ Precis Oncol. 2024; 8(1):20.

PMID: 38273040 PMC: 10810864. DOI: 10.1038/s41698-024-00496-y.

Regulation of Cell Cycle Progression by Growth Factor-Induced Cell Signaling.

Wang Z Cells. 2021; 10(12).

PMID: 34943835 PMC: 8699227. DOI: 10.3390/cells10123327.

Extracellular ATP Induced S-Phase Cell Cycle Arrest via P2Y Receptor-Activated ERK Signaling in Poorly Differentiated Oral Squamous Cell Carcinoma SAS Cells.

Lau C, Aminuddin A, Chan K, Paterson I, Law L, Ng P Life (Basel). 2021; 11(11).

PMID: 34833046 PMC: 8624497. DOI: 10.3390/life11111170.

p21-Activated Kinase 4 Promotes Intimal Hyperplasia and Vascular Smooth Muscle Cells Proliferation during Superficial Femoral Artery Restenosis after Angioplasty.

Yuan L, Duan X, Dong J, Lu Q, Zhou J, Zhao Z Biomed Res Int. 2017; 2017:5296516.

PMID: 28706947 PMC: 5494543. DOI: 10.1155/2017/5296516.

Thrombomodulin regulates monocye differentiation via PKCδ and ERK1/2 pathway in vitro and in atherosclerotic artery.

Tsai C, Lin Y, Huang C, Shih C, Tsai Y, Tsao N Sci Rep. 2016; 6:38421.

PMID: 27910925 PMC: 5133669. DOI: 10.1038/srep38421.

References
1.
Schwartz M, Lechene C, Ingber D . Insoluble fibronectin activates the Na/H antiporter by clustering and immobilizing integrin alpha 5 beta 1, independent of cell shape. Proc Natl Acad Sci U S A. 1991; 88(17):7849-53. PMC: 52401. DOI: 10.1073/pnas.88.17.7849. View
2.
Weber J, Raben D, Phillips P, Baldassare J . Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. Biochem J. 1997; 326 ( Pt 1):61-8. PMC: 1218637. DOI: 10.1042/bj3260061. View
3.
El-Deiry W, Tokino T, Velculescu V, Levy D, Parsons R, Trent J . WAF1, a potential mediator of p53 tumor suppression. Cell. 1993; 75(4):817-25. DOI: 10.1016/0092-8674(93)90500-p. View
4.
Vlahos C, Matter W, Hui K, Brown R . A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem. 1994; 269(7):5241-8. View
5.
Li Y, Jenkins C, Nichols M, Xiong Y . Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene. 1994; 9(8):2261-8. View